Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and JAK inhibitors: A case series

J Eur Acad Dermatol Venereol. 2024 Oct;38(10):e852-e854. doi: 10.1111/jdv.19929. Epub 2024 Feb 29.
No abstract available

Publication types

  • Letter
  • Case Reports

MeSH terms

  • Adult
  • Aged
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Dermatitis, Atopic / drug therapy
  • Female
  • Humans
  • Janus Kinase Inhibitors* / therapeutic use
  • Male
  • Middle Aged

Substances

  • Antibodies, Monoclonal, Humanized
  • dupilumab
  • Janus Kinase Inhibitors
  • Antibodies, Monoclonal